63 related articles for article (PubMed ID: 30719695)
41. Dual time point 18F-FDG PET imaging for differentiating malignant from inflammatory processes.
Zhuang H; Pourdehnad M; Lambright ES; Yamamoto AJ; Lanuti M; Li P; Mozley PD; Rossman MD; Albelda SM; Alavi A
J Nucl Med; 2001 Sep; 42(9):1412-7. PubMed ID: 11535734
[TBL] [Abstract][Full Text] [Related]
42. Glucose transporter glut-1 expression correlates with tumor hypoxia and predicts metastasis-free survival in advanced carcinoma of the cervix.
Airley R; Loncaster J; Davidson S; Bromley M; Roberts S; Patterson A; Hunter R; Stratford I; West C
Clin Cancer Res; 2001 Apr; 7(4):928-34. PubMed ID: 11309343
[TBL] [Abstract][Full Text] [Related]
43. FDG-PET of autoimmune-related pancreatitis: preliminary results.
Nakamoto Y; Saga T; Ishimori T; Higashi T; Mamede M; Okazaki K; Imamura M; Sakahara H; Konishi J
Eur J Nucl Med; 2000 Dec; 27(12):1835-8. PubMed ID: 11189947
[TBL] [Abstract][Full Text] [Related]
44. Facilitative glucose transporter expression in human cancer tissue.
Smith TA
Br J Biomed Sci; 1999; 56(4):285-92. PubMed ID: 10795374
[TBL] [Abstract][Full Text] [Related]
45. Dual time point fluorine-18 fluorodeoxyglucose positron emission tomography: a potential method to differentiate malignancy from inflammation and normal tissue in the head and neck.
Hustinx R; Smith RJ; Benard F; Rosenthal DI; Machtay M; Farber LA; Alavi A
Eur J Nucl Med; 1999 Oct; 26(10):1345-8. PubMed ID: 10541835
[TBL] [Abstract][Full Text] [Related]
46. Focal fluorine-18 fluorodeoxyglucose accumulation in inflammatory pancreatic disease.
Shreve PD
Eur J Nucl Med; 1998 Mar; 25(3):259-64. PubMed ID: 9580859
[TBL] [Abstract][Full Text] [Related]
47. FDG uptake, tumor proliferation and expression of glycolysis associated genes in animal tumor models.
Haberkorn U; Ziegler SI; Oberdorfer F; Trojan H; Haag D; Peschke P; Berger MR; Altmann A; van Kaick G
Nucl Med Biol; 1994 Aug; 21(6):827-34. PubMed ID: 9234332
[TBL] [Abstract][Full Text] [Related]
48. Dual control of glut1 glucose transporter gene expression by hypoxia and by inhibition of oxidative phosphorylation.
Behrooz A; Ismail-Beigi F
J Biol Chem; 1997 Feb; 272(9):5555-62. PubMed ID: 9038162
[TBL] [Abstract][Full Text] [Related]
49. Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose.
Rigo P; Paulus P; Kaschten BJ; Hustinx R; Bury T; Jerusalem G; Benoit T; Foidart-Willems J
Eur J Nucl Med; 1996 Dec; 23(12):1641-74. PubMed ID: 8929320
[TBL] [Abstract][Full Text] [Related]
50. Fluorine-18 deoxyglucose and false-positive results: a major problem in the diagnostics of oncological patients.
Strauss LG
Eur J Nucl Med; 1996 Oct; 23(10):1409-15. PubMed ID: 8781149
[TBL] [Abstract][Full Text] [Related]
51. High accumulation of fluorine-18-fluorodeoxyglucose in turpentine-induced inflammatory tissue.
Yamada S; Kubota K; Kubota R; Ido T; Tamahashi N
J Nucl Med; 1995 Jul; 36(7):1301-6. PubMed ID: 7790960
[TBL] [Abstract][Full Text] [Related]
52. Determination of hexokinase isoenzyme I and II composition by RT-PCR: increased hexokinase isoenzyme II in human renal cell carcinoma.
Adams V; Kempf W; Hassam S; Briner J
Biochem Mol Med; 1995 Feb; 54(1):53-8. PubMed ID: 7551817
[TBL] [Abstract][Full Text] [Related]
53. Signaling Pathways That Drive
Salas JR; Clark PM
J Nucl Med; 2022 May; 63(5):659-663. PubMed ID: 35241480
[No Abstract] [Full Text] [Related]
54. Glucose-6-phosphatase Expression-Mediated [
Kim MJ; Lee CH; Lee Y; Youn H; Kang KW; Kwon J; Alavi A; Carlin S; Cheon GJ; Chung JK
Mol Imaging Biol; 2019 Oct; 21(5):917-925. PubMed ID: 30719695
[TBL] [Abstract][Full Text] [Related]
55. Predicting tumour response to anti-HER1 therapy using medical imaging: a literature review and in vitro study of [18F]-FDG incorporation by breast cancer cells responding to cetuximab.
Smith TA; Cheyne RW
Br J Biomed Sci; 2011; 68(3):158-66. PubMed ID: 21950209
[TBL] [Abstract][Full Text] [Related]
56.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
